A Safety and Efficacy Study of LYS-GM101 Gene Therapy in Patients With GM1 Gangliosidosis

Clinical trial NCT04273269 · TERMINATED

Trial details

NCT number: NCT04273269
Sponsor: LYSOGENE
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

GM1 Gangliosidosis

Start date: 2021-05-11
Primary completion: 2023-05-22
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.